InMode Announces New Share Repurchase Program
Rhea-AI Summary
InMode (Nasdaq: INMD) on March 13, 2026 authorized a new share repurchase program for up to approximately 10% of shares outstanding (about 6.38 million ordinary shares). The company said it repurchased roughly $127.4 million of shares in 2025 and expects to fund repurchases with available cash.
Repurchases may occur in the open market or by other permitted means, are subject to market and legal conditions, and the program may be modified, suspended, or discontinued at the company's discretion.
Positive
- Authorized buyback up to 10% (~6.38 million shares)
- Repurchased $127.4 million of shares in 2025
- Repurchases to be funded with available cash, per the company
Negative
- Program may be modified, suspended, or discontinued at any time
- Repurchases are subject to market conditions and legal requirements
Key Figures
Market Reality Check
Peers on Argus
INMD shows a pre-news decline of -2.89% while device peers are mixed: IRMD up 0.74%, IART down 2.03%, TNDM down 2.95%, BBNX down 4.08%, SSII down 0.6%. Momentum scanner only flagged AHCO up 1.23%, suggesting stock-specific drivers rather than a broad sector move.
Previous Buybacks Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Sep 10 | Share repurchase | Positive | +8.8% | New repurchase program of up to 7.68M shares funded with cash. |
Prior buyback news on Sep 10, 2024 coincided with a positive +8.83% next-day move, indicating historically favorable reactions to repurchase announcements.
This announcement follows an earlier buyback communication on Sep 10, 2024, when InMode authorized a share repurchase program of up to 7.68 million shares, funded with available cash and framed as a reflection of confidence in its long-term outlook. That prior buyback headline saw a +8.83% 24-hour price reaction. Today’s new program, again funded with cash and focused on capital allocation, extends this pattern of returning capital to shareholders.
Historical Comparison
Over the past 18 months, INMD reported one prior buyback announcement, linked to a +8.83% move. The new repurchase program continues this capital-return theme against similar cash-rich conditions.
The company has progressed from a 2024 repurchase authorization of up to 7.68 million shares to a new 2026 program targeting up to roughly 10% of shares outstanding, again funded with available cash.
Market Pulse Summary
This announcement details a new share repurchase program for up to roughly 10% of InMode’s outstanding shares, or about 6.38 million ordinary shares, funded entirely with available cash. It builds on prior repurchases of $127.4 million in 2025 and continues a capital-return focus. Investors may monitor how quickly the authorization is used, any changes in future buyback plans, and how this fits alongside growth investments amid macro and regional uncertainties.
Key Terms
AI-generated analysis. Not financial advice.
YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately
In 2025, the Company repurchased approximately
While management remains focused on navigating the ongoing regional conflict and maintaining a disciplined approach to capital allocation, the Company will continue to evaluate additional share repurchase programs and other capital allocation opportunities going forward.
The Company expects to fund repurchases under the program with available cash. Repurchases may be made from time to time in the open market or through other permitted means, subject to market conditions and applicable legal requirements. The program may be modified, suspended, or discontinued at any time at the Company's discretion.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com/.
Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.
Company Contact: Yair Malca Chief Financial Officer Phone: (949) 305-0108 Email: Yair.Malca@inmodemd.com | Investor Relations Contact Miri Segal MS-IR LLC Email: ir@inmodemd.com |
Logo - https://mma.prnewswire.com/media/1064477/5862039/InMode_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-announces-new-share-repurchase-program-302712849.html
SOURCE InMode Ltd.
FAQ
What is InMode's March 13, 2026 buyback program for INMD?
How will InMode (INMD) fund the new repurchase program?
How much did InMode repurchase in 2025 before the 2026 program?
Can InMode (INMD) stop or change the March 2026 buyback program?
Will the INMD buyback definitely reduce share count immediately?